• Je něco špatně v tomto záznamu ?

Surveillance of non-muscle-invasive bladder cancer with blue-light cystoscopy: a meta-analysis

R. Sari Motlagh, A. Ghoreifi, T. Yanagisawa, T. Kawada, S. Ahyai, AS. Merseburger, M. Abufaraj, M. Abern, H. Djaladat, S. Daneshmand, SF. Shariat

. 2024 ; 134 (4) : 526-533. [pub] 20240424

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, metaanalýza, systematický přehled, srovnávací studie, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc24018823

OBJECTIVE: To compare the value of flexible blue-light cystoscopy (BLC) vs flexible white-light cystoscopy (WLC) in the surveillance setting of non-muscle-invasive bladder cancer (NMIBC). METHODS: All major databases were searched for articles published before May 2023 according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. The primary outcome was the accuracy of flexible BLC vs WLC in detecting bladder cancer recurrence among suspicious bladder lesions. RESULTS: A total of 10 articles, comprising 1634 patients, were deemed eligible for the quantitative synthesis. In the meta-analysis focusing on the detection of disease recurrence, there was no difference between flexible BLC and WLC (odds ratio [OR] 1.08, 95% confidence interval [CI] 0.82-1.41)]; the risk difference (RD) showed 1% of flexible BLC, corresponding to a number needed to treat (NNT) of 100. In the subgroup meta-analysis of detection of carcinoma in situ (CIS) only, there was again no significant difference between flexible BLC and WLC (OR 1.19, 95% CI 0.82-1.69), BLC was associated with a RD of 2% (NNT = 50). The positive predictive values for flexible BLC and WLC in detecting all types of recurrence were 72% and 66%, respectively, and for CIS they were 39% and 29%, respectively. CONCLUSION: Surveillance of NMIBC with flexible BLC could detect more suspicious lesions and consequently more tumour recurrences compared to flexible WLC, with a increase in the rate of false positives leading to overtreatment. A total of 100 and 50 flexible BLC procedures would need to be performed to find on additional tumor and CIS recurences, respectively. A risk-stratified strategy for patient selection could be considered when using flexible BLC for the surveillance of NMIBC patients.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24018823
003      
CZ-PrNML
005      
20241024111329.0
007      
ta
008      
241015s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/bju.16364 $2 doi
035    __
$a (PubMed)38658172
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Sari Motlagh, Reza $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria $1 https://orcid.org/0000000238199911
245    10
$a Surveillance of non-muscle-invasive bladder cancer with blue-light cystoscopy: a meta-analysis / $c R. Sari Motlagh, A. Ghoreifi, T. Yanagisawa, T. Kawada, S. Ahyai, AS. Merseburger, M. Abufaraj, M. Abern, H. Djaladat, S. Daneshmand, SF. Shariat
520    9_
$a OBJECTIVE: To compare the value of flexible blue-light cystoscopy (BLC) vs flexible white-light cystoscopy (WLC) in the surveillance setting of non-muscle-invasive bladder cancer (NMIBC). METHODS: All major databases were searched for articles published before May 2023 according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. The primary outcome was the accuracy of flexible BLC vs WLC in detecting bladder cancer recurrence among suspicious bladder lesions. RESULTS: A total of 10 articles, comprising 1634 patients, were deemed eligible for the quantitative synthesis. In the meta-analysis focusing on the detection of disease recurrence, there was no difference between flexible BLC and WLC (odds ratio [OR] 1.08, 95% confidence interval [CI] 0.82-1.41)]; the risk difference (RD) showed 1% of flexible BLC, corresponding to a number needed to treat (NNT) of 100. In the subgroup meta-analysis of detection of carcinoma in situ (CIS) only, there was again no significant difference between flexible BLC and WLC (OR 1.19, 95% CI 0.82-1.69), BLC was associated with a RD of 2% (NNT = 50). The positive predictive values for flexible BLC and WLC in detecting all types of recurrence were 72% and 66%, respectively, and for CIS they were 39% and 29%, respectively. CONCLUSION: Surveillance of NMIBC with flexible BLC could detect more suspicious lesions and consequently more tumour recurrences compared to flexible WLC, with a increase in the rate of false positives leading to overtreatment. A total of 100 and 50 flexible BLC procedures would need to be performed to find on additional tumor and CIS recurences, respectively. A risk-stratified strategy for patient selection could be considered when using flexible BLC for the surveillance of NMIBC patients.
650    12
$a nádory močového měchýře $x patologie $x diagnóza $7 D001749
650    _2
$a lidé $7 D006801
650    12
$a cystoskopie $x metody $7 D003558
650    _2
$a lokální recidiva nádoru $7 D009364
650    _2
$a invazivní růst nádoru $7 D009361
650    _2
$a nádory močového měchýře neinvadující svalovinu $7 D000093284
655    _2
$a časopisecké články $7 D016428
655    _2
$a metaanalýza $7 D017418
655    _2
$a systematický přehled $7 D000078182
655    _2
$a srovnávací studie $7 D003160
655    _2
$a přehledy $7 D016454
700    1_
$a Ghoreifi, Alireza $u Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA $1 https://orcid.org/0000000273687240
700    1_
$a Yanagisawa, Takafumi $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria $u Department of Urology, The Jikei University School of Medicine, Tokyo, Japan $1 https://orcid.org/0000000274100712
700    1_
$a Kawada, Tatsushi $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria $u Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan $1 https://orcid.org/0000000283699712
700    1_
$a Ahyai, Sascha $u Department of Urology, Medical University of Graz, Graz, Austria
700    1_
$a Merseburger, Axel S $u Department of Urology, Campus Lübeck, University Hospital Schleswig-Holstein, Lübeck, Germany
700    1_
$a Abufaraj, Mohammad $u Division of Urology, Department of Special Surgery, Jordan University Hospital, The University of Jordan, Amman, Jordan $u The National Center for Diabetes, Endocrinology and Genetics, The University of Jordan, Amman, Jordan $1 https://orcid.org/0000000266036319
700    1_
$a Abern, Michael $u Department of Urology, Duke University, Durham, NC, USA
700    1_
$a Djaladat, Hooman $u Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA $1 https://orcid.org/0000000219843556
700    1_
$a Daneshmand, Siamak $u Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA $1 https://orcid.org/0000000162249598 $7 ntk20221160751
700    1_
$a Shariat, Shahrokh F $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria $u Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria $u Department of Urology, Weill Cornell Medical College, New York, NY, USA $u Department of Urology, University of Texas Southwestern, Dallas, TX, USA $u Division of Urology, Department of Special Surgery, Jordan University Hospital, The University of Jordan, Amman, Jordan $u Institute for Urology and Reproductive Health, I.M. Sechenov First Moscow State Medical University, Moscow, Russia $u Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic
773    0_
$w MED00011371 $t BJU international $x 1464-410X $g Roč. 134, č. 4 (2024), s. 526-533
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38658172 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241015 $b ABA008
991    __
$a 20241024111323 $b ABA008
999    __
$a ok $b bmc $g 2201591 $s 1230796
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 134 $c 4 $d 526-533 $e 20240424 $i 1464-410X $m BJU international $n BJU Int $x MED00011371
LZP    __
$a Pubmed-20241015
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace